v3.26.1
Condensed Consolidated Statement of Cash Flows (unaudited) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Operating activities          
Net income $ 410 $ 352 $ 729 $ 127  
Reconciliation of net income to net cash provided by operating activities          
Depreciation and amortization     756 690  
Goodwill impairment 0 0 0 305 $ 305
Provision for credit losses 430 384 897 575  
Loss on mortgage and automotive loans, net 6 4 9 3  
Other (gain) loss on investments, net (76) (61) (55) 438  
Loss on extinguishment of debt 2 0 2 0  
Originations and purchases of loans held-for-sale     (1,770) (912)  
Proceeds from sales and repayments of loans held-for-sale     1,645 1,044  
Net change in          
Deferred income taxes     45 (249)  
Interest payable     166 22  
Other assets     101 (153)  
Other liabilities     80 (115)  
Other, net     119 112  
Net cash provided by operating activities     2,724 1,887  
Investing activities          
Purchases of equity securities     (558) (397)  
Proceeds from sales of equity securities     652 376  
Purchases of available-for-sale securities     (1,627) (4,493)  
Proceeds from sales of available-for-sale securities     153 4,157  
Proceeds from repayments of available-for-sale securities     1,088 954  
Purchases of held-to-maturity securities     (108) (412)  
Proceeds from repayments of held-to-maturity securities     247 238  
Purchases of finance receivables and loans held-for-investment     (4,087) (2,192)  
Proceeds from sales of finance receivables and loans initially held-for-investment     256 5  
Originations and repayments of finance receivables and loans initially held-for-investment and other, net     (3,006) 1,701  
Purchases of operating lease assets     (1,429) (1,900)  
Disposals of operating lease assets     1,049 1,453  
Proceeds from sale of operation or business unit, net     0 2,412  
Net change in nonmarketable equity investments     (26) (36)  
Other, net     (243) (298)  
Net cash (used in) provided by investing activities     (7,639) 1,568  
Financing activities          
Net change in short-term borrowings     1,221 2,231  
Net increase (decrease) in deposits     2,487 (3,626)  
Proceeds from issuance of long-term debt     1,877 953  
Repayments of long-term debt     (1,941) (2,612)  
Repurchases of common stock     (295) (35)  
Preferred stock issuance     987 0  
Preferred stock redemption     (1,350) 0  
Common stock dividends paid     (194) (192)  
Preferred stock dividends paid     (56) (56)  
Net cash provided by (used in) financing activities     2,736 (3,337)  
Effect of exchange-rate changes on cash and cash equivalents and restricted cash     (7) 10  
Net (decrease) increase in cash and cash equivalents and restricted cash     (2,186) 128  
Cash and cash equivalents and restricted cash at beginning of year     11,809 11,380 11,380
Cash and cash equivalents and restricted cash at June 30, 9,623 11,508 9,623 11,508 11,809
Cash paid for          
Interest     2,814 3,202  
Income taxes     152 108  
Noncash items          
Loans held-for-sale transferred to finance receivables and loans held-for-investment     33 19  
Finance receivables and loans held-for-investment transferred to loans held-for-sale     33 2,391  
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]          
Cash and cash equivalents on the Condensed Consolidated Balance Sheet 7,840 10,592 7,840 10,592 10,030
Restricted cash and cash equivalents and restricted cash held for securitization trusts included in other assets on the Condensed Consolidated Balance Sheet [1] 1,783 916 1,783 916  
Total cash and cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows $ 9,623 $ 11,508 $ 9,623 $ 11,508 $ 11,809
[1] Refer to Note 10 for additional details describing the nature of restricted cash and cash equivalent balances.